JSE-listed Cell C’s maiden interim financial results after its listing shows some improvements as the company transitions to its next phase as a financially stronger business following the successful ...
Tokyo, Japan and Cambridge, UK, 13 February 2026 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) provides an update on operational activities and reports its consolidated results for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results